These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 27825472)
21. 12th International Conference on Antiviral Research. Jerusalem, Israel, March 21-25, 1999. Abstracts. Antiviral Res; 1999 Mar; 41(2):A31-75. PubMed ID: 10372192 [No Abstract] [Full Text] [Related]
22. Computational protein modeling and the next viral pandemic. Narykov O; Srinivasan S; Korkin D Nat Methods; 2021 May; 18(5):444-445. PubMed ID: 33963340 [No Abstract] [Full Text] [Related]
23. Summary of presentations from the International Workshop on Antiviral Drug Resistance: Meeting the Global Challenge, 3-7 June 2014, Berlin, Germany. Parkin N Antivir Ther; 2014; 19(7):701-17. PubMed ID: 25431873 [No Abstract] [Full Text] [Related]
25. Contribution of molecular biology to the understanding and control of microbial infections. Pittard AJ J Dent Res; 1984 Mar; 63(3):374-7. PubMed ID: 6607939 [No Abstract] [Full Text] [Related]
26. Abstracts of the 20th International Conference on Antiviral Research (ICAR), April 29-May 3, 2007, Palm Springs, California, USA. Antiviral Res; 2007 Jun; 74(3):A27-89. PubMed ID: 17536235 [No Abstract] [Full Text] [Related]
27. Editorial overview: vaccines against challenging viral pathogens and new vaccine technology. Lu S Curr Opin Virol; 2014 Jun; 6():viii-ix. PubMed ID: 24831092 [No Abstract] [Full Text] [Related]
28. Abstracts of the 17th International Conference on Antiviral Research. Tucson, Arizona, USA. May 2-6, 2004. Antiviral Res; 2004 May; 62(2):A27-90. PubMed ID: 15185686 [No Abstract] [Full Text] [Related]
29. The 10th International Conference on Antiviral Research. Atlanta, Georgia, USA, April 6-11, 1997. Abstracts. Antiviral Res; 1997 Apr; 34(2):A1-95. PubMed ID: 9164488 [No Abstract] [Full Text] [Related]
30. Viral respiratory diseases. Report of a WHO Scientific Group. World Health Organ Tech Rep Ser; 1980; 642():1-63. PubMed ID: 6771925 [No Abstract] [Full Text] [Related]
31. Antiviral agents in practice. Can Med Assoc J; 1968 Jun; 98(22):1066-8. PubMed ID: 5661063 [No Abstract] [Full Text] [Related]
32. [Mechanism of action of antiviral drugs]. Shiraki K; Daikoku T; Takemoto M; Himaki T; Kuramoto T Nihon Rinsho; 2012 Apr; 70(4):545-51. PubMed ID: 22568132 [TBL] [Abstract][Full Text] [Related]
33. The program of antiviral agents inhibits virus infection. Ding YZ; Lv JL; Zhang ZW; Ma XY; Zhang J; Zhang YG Arch Microbiol; 2018 Aug; 200(6):841-846. PubMed ID: 29846759 [TBL] [Abstract][Full Text] [Related]
34. [Elements of the systems approach in studying and using antiviral preparations]. Pshenichnov VA Vopr Virusol; 1989; 34(2):139-45. PubMed ID: 2669332 [No Abstract] [Full Text] [Related]
35. [Viral infections in immunocompromised patients]. Frostad S; Sjursen H; Solberg CO; Haukenes G Tidsskr Nor Laegeforen; 1990 Sep; 110(21):2765-9. PubMed ID: 2219051 [TBL] [Abstract][Full Text] [Related]
36. Antibodies, viruses and vaccines. Burton DR Nat Rev Immunol; 2002 Sep; 2(9):706-13. PubMed ID: 12209139 [TBL] [Abstract][Full Text] [Related]
37. Antiviral resistance and impact on viral replication capacity: evolution of viruses under antiviral pressure occurs in three phases. Nijhuis M; van Maarseveen NM; Boucher CA Handb Exp Pharmacol; 2009; (189):299-320. PubMed ID: 19048205 [TBL] [Abstract][Full Text] [Related]